178 studies found for:    "Children's Hospital of Wisconsin"
Show Display Options
Rank Status Study
21 Completed Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Conditions: Cancer;   Breakthrough Pain
Intervention: Drug: ACTIQ®
22 Completed Vascular Malformations and Abnormalities of Growth
Condition: Abnormality
Intervention: Procedure: skin biopsy
23 Recruiting Study to Evaluate a Single Dose of Apixaban in Pediatric Subjects at Risk for a Thrombotic Disorder
Condition: Thromboembolism
Intervention: Drug: Apixaban
24 Completed The Second Multicenter Hemophilia Cohort Study
Conditions: Liver Decompensation;   Hepatocellular Carcinoma;   Non-Hodgkin Lymphoma
Intervention:
25 Recruiting Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)
Condition: Cystic Fibrosis
Interventions: Drug: Ataluren (PTC124®);   Drug: Placebo
26 Recruiting An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165
Condition: Phenylketonuria
Intervention: Drug: BMN 165
27 Completed
Has Results
An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease
Condition: Gaucher Disease, Type 1
Intervention: Biological: VPRIV®
28 Active, not recruiting Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
Condition: Juvenile Idiopathic Arthritis
Intervention: Other: Withdrawal of anti-TNF therapy
29 Completed
Has Results
Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency
Conditions: Childhood-onset Growth Hormone Deficiency;   Pituitary Dwarfism
Intervention: Biological: recombinant human growth hormone
30 Recruiting Etanercept in Kawasaki Disease
Conditions: Mucocutaneous Lymph Node Syndrome;   Kawasaki Disease
Interventions: Drug: Etanercept;   Drug: Placebo
31 Completed Transition From Hospital to Home in Solid Organ Transplant (SOT)
Condition: Solid Organ Transplant
Intervention:
32 Recruiting Discharge to Home and Chronic Illness Care Pilot
Condition: Solid Organ Transplant
Intervention: Behavioral: myFAMI iPad application
33 Recruiting Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
Conditions: Ewing Sarcoma;   Neuroblastoma;   Rhabdomyosarcoma
Interventions: Procedure: Allogeneic HCT;   Drug: Donor NK Cell Infusion
34 Completed Natural History of Urticaria Pigmentosa in Children
Condition: Urticaria Pigmentosa
Intervention:
35 Active, not recruiting Video Education: Capitalizing on Caregiver Time Spent in the Pediatric Emergency Department Waiting Room
Condition: Child Passenger Seat Safety
Intervention: Other: Child passenger safety video
36 Completed The Influence of Expectations on Patient Satisfaction in the Pediatric Emergency Department
Condition: Patient Satisfaction
Intervention: Behavioral: Physician knowledge of parental expectations for the visit
37 Unknown  Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
Conditions: Crohn's Disease;   Ulcerative Colitis;   Inflammatory Bowel Disease
Intervention:
38 Active, not recruiting Genetic Basis of Hemangiomas
Condition: Hemangioma, Vascular Anomalies
Interventions: Genetic: Cheek cell samples or blood sample (4mL);   Genetic: Cheek cell sample or blood sample (4mL)
39 Active, not recruiting Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia
Conditions: Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Childhood Acute Myeloid Leukemia in Remission;   Childhood Myelodysplastic Syndromes;   de Novo Myelodysplastic Syndromes;   Fanconi Anemia;   Previously Treated Myelodysplastic Syndromes
Interventions: Drug: fludarabine phosphate;   Drug: cyclophosphamide;   Radiation: total-body irradiation;   Procedure: allogeneic bone marrow transplantation;   Drug: mycophenolate mofetil;   Drug: cyclosporine;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Other: laboratory biomarker analysis
40 Completed A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients
Conditions: Mucopolysaccharidosis I;   Hurler's Syndrome;   Hurler-Scheie Syndrome;   Scheie's Syndrome
Intervention: Drug: laronidase

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years